Vachon Cognitive-Memory
Natural health product licensed in Canada
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80078349
- Status
- Inactive licence
- Licence date
- 13 June 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rhodiola rosea Source : Rhodiola rosea - Racine Potency : 2.65 % Salidroside | 100 milligramme | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 6 Grammes Potency : 24 % Flavonoid glycosides | 120 milligramme | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Phosphatidylsérine Source : Phosphatidylserine | 150 milligramme | Not calculated |
| Withania somnifera Source : Withania somnifera - racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,200 milligramme Potency : 2 % Withanolides | 120 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Helps to support cognitive function. Helps to enhance cognitive function in adults. Helps to enhance memory in adults. Helps to support peripheral circulation. Ashawagandha is traditionally used in Ayurveda for memory enhancement. Used in Herbal Medicine to help support cognitive function such as mental focus and mental stamina. Used in Herbal Medicine as an adaptogen to help temporary relieve symptoms of stress such as mental fatigue and sensation of weakness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you experience irritability or insomnia, discontinue use.
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. If you have bipolar disorder or bipolar spectrum disorder, do not use this product.
- Précautions et mises en garde
If symptoms persist or worsen, consult a health care practitioner. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking medications for diabetes, high blood pressure, or seizures. If you are taking antidepressant medication, consult a health care practitioner prior to use. If you are taking hormone replacement therapy (HRT) or birth control pills, consult a health care practitioner prior to use. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended.
Source
Official Health Canada record, licence 80078349
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.